REG - Frontier IP Group - Board Changes

Frontier IPAnnouncement

25/09/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250925:nRSY7148Aa&default-theme=true

RNS Number : 7148A  Frontier IP Group plc  25 September 2025

RNS

AIM: FIPP

25 September 2025

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

Announcement of Board Change

 

Frontier IP, a specialist in commercialising intellectual property, today
announces that

Matthew White (Chief Commercialisation Officer) has decided to leave the Group
to pursue an opportunity as Chief Executive Officer of a Cambridge based
early-stage medical devices company.

 

It is currently intended that Mr White will remain with the Company as Chief
Commercialisation Officer and an Executive Director of the Company until the
end of his six month notice period on 24 March 2026.

 

The Group is in discussions about a successor and a further update will be
issued when appropriate.

 

Frontier IP Chief Executive Officer Neil Crabb said: "I am sorry Matt is
leaving the Group. His departure is wholly amicable. In the seven years he has
been our Chief Commercialisation Officer, he has played an invaluable role in
the progress made by Frontier IP and our portfolio companies. I would like to
wish him all the best in the exciting role he is to fulfil. I am sure he will
be a great success."

 

Frontier IP Chief Commercialisation Officer Matthew White said: "It has been a
privilege to be involved in the development of the Frontier IP portfolio over
the last seven years. I look forward to the continued success of the portfolio
and Frontier IP's growing engagement in the Cambridge deeptech ecosystem."

 

 

ENQUIRIES

 

 Frontier IP Group Plc                                                  T: 020 7332 2338
 Neil Crabb, Chief Executive                                            neil@frontierip.co.uk

 Andrew Johnson, Communications & Investor Relations                    M: 07464 546 025

 Company website: www.frontierip.co.uk (http://www.frontierip.co.uk/)

 Allenby Capital Limited (Nominated Adviser)                            T: 0203 328 5656

 Nick Athanas / Daniel Dearden-Williams

 Singer Capital Markets (Broker)                                        T: 0207 496 3000

 Charles Leigh-Pemberton / James Fischer

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOALIMPTMTMTBBA